These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 947135)

  • 21. Effect of a steroidal alkylating agent (estramustine phosphate) in rat ventral prostate.
    Høisaeter PA
    Scand J Urol Nephrol Suppl; 1977; (46):1-72. PubMed ID: 279091
    [No Abstract]   [Full Text] [Related]  

  • 22. Metabolic aspects and actions unique to Estracyt.
    Sandberg AA
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):3-15. PubMed ID: 6364364
    [No Abstract]   [Full Text] [Related]  

  • 23. Subcellular localization of estramustine in rat ventral prostate following intravenous injection.
    Peterson C; Forsgren B; Högberg B
    Acta Physiol Scand Suppl; 1983; 515():55-63. PubMed ID: 6578672
    [No Abstract]   [Full Text] [Related]  

  • 24. Incorporation of 3H-thymidine into rat ventral prostate in organ culture. Influence of hormone-cytostatic complexes.
    Hoisaeter PA
    Invest Urol; 1975 May; 12(6):479-89. PubMed ID: 1120641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific binding of estramustine to prostatic proteins.
    Forsgren B; Björk P
    Urology; 1984 Jun; 23(6 Suppl):34-8. PubMed ID: 6375077
    [No Abstract]   [Full Text] [Related]  

  • 26. Uptake of estramustine phosphate (estracyt) metabolites in prostatic cancer.
    Norlén BJ; Andersson SB; Björk P; Gunnarsson PO; Fritjofsson A
    J Urol; 1988 Nov; 140(5):1058-62. PubMed ID: 3172360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of hormone-cytostatic complexes on the rat ventral prostate in vivo and in vitro.
    Forsberg JG; Hoisaeter PA
    Vitam Horm; 1975; 33():137-54. PubMed ID: 180672
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition by estramustine phosphate on estradiol and androgen binding in benign and malignant prostate in humans.
    Nilsson I; Liskowski L; Nilsson T
    Urology; 1976 Aug; 8(2):118-21. PubMed ID: 60819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma concentrations of estramustine phosphate and its major metabolites in patients with prostatic carcinoma treated with different doses of estramustine phosphate (Estracyt).
    Gunnarsson PO; Forshell GP; Fritjofsson A; Norlén BJ
    Scand J Urol Nephrol; 1981; 15(3):201-5. PubMed ID: 7323739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative affinities of estramustine phosphate metabolites to the cytosol oestrogen receptor of rat testis.
    Daehlin L; Södergård R; Damber JE
    Scand J Clin Lab Invest; 1986 Apr; 46(2):159-62. PubMed ID: 3715367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pilot study on the growth inhibition by estramustine phosphate (Estracyt) of rat mammary tumours sensitive and insensitive of oestrogen.
    Müntzing J; Jensen G; Högberg B
    Acta Pharmacol Toxicol (Copenh); 1979 Jan; 44(1):1-6. PubMed ID: 104546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partial characterization and "quantitation" of a human prostatic estramustine-binding protein.
    Björk P; Forsgren B; Gustafsson JA; Pousette A; Högberg B
    Cancer Res; 1982 May; 42(5):1935-42. PubMed ID: 7066904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of estramustine phosphate (Estracyt) in prostatic cancer patients.
    Gunnarsson PO; Andersson SB; Johansson SA; Nilsson T; Plym-Forshell G
    Eur J Clin Pharmacol; 1984; 26(1):113-9. PubMed ID: 6714283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of estramustine, a nitrogen mustard derivative of estradiol-17 beta, in cytosol from rat ventral prostate.
    Forsgren B; Högberg B; Gustafsson JA; Pousette A
    Acta Pharm Suec; 1978; 15(1):23-32. PubMed ID: 645366
    [No Abstract]   [Full Text] [Related]  

  • 35. Interaction of the cytotoxic agent estramustine phosphate (Estracyt) with the estrogen receptor of the human uterus.
    Muechler EK; Kohler D
    Gynecol Oncol; 1979 Dec; 8(3):330-8. PubMed ID: 510999
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical pharmacokinetics of estramustine phosphate.
    Gunnarsson PO; Forshell GP
    Urology; 1984 Jun; 23(6 Suppl):22-7. PubMed ID: 6375076
    [No Abstract]   [Full Text] [Related]  

  • 37. Intracellular effects of estramustine (Estracyt/Emcyt).
    Tew KD; Stearns ME
    Prog Clin Biol Res; 1989; 303():169-75. PubMed ID: 2674983
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of estracyt on the rat prostate.
    Yamanaka H; Shimazaki J; Imai K; Sugiyama Y; Shida K
    Invest Urol; 1977 Mar; 14(5):400-4. PubMed ID: 845006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uptake in vivo of 45Ca in male accessory sex organs of the rat: effect of estramustine phosphate and diethylstilbestrol diphosphate.
    Batra S; Müntzing J
    Eur J Pharmacol; 1981 Nov; 76(1):87-91. PubMed ID: 7318924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.
    Schindler AE; Bolt HM; Zwirner M; Hochlehnert G; Göser R
    Arzneimittelforschung; 1982; 32(7):787-91. PubMed ID: 6289846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.